The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

Indiana wants to discontinue Medicaid reimbursement for drugs purchased under a federal program designed to help hospitals ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

The change is expected to save the state’s Medicaid program approximately $63 million annually, but safety-net care providers ...

Providers claim a proposed change to Indiana's 340B Drug Program could cut services and harm health care providers.

Health centers warn they could lose millions in rebates under the states proposed change, which would end Medicaid drug ...

A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B ...

On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B ...

The drug discount program is under scrutiny on a variety of fronts ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.